Nuveen Asset Management, LLC Harmony Biosciences Holdings, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 212,351 shares of HRMY stock, worth $7.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

212,351

Previous 204,158 4.01%

Holding current value

$7.23 Million

Previous $8.16 Million 10.42%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$31.86 - $41.49 $261,028 - $339,927	8,193 Added 4.01%	212,351 $7.31 Million
Q2 2024 Aug 09, 2024	SELL	$28.81 - $33.01 $5.74 Million - $6.58 Million	-199,211 Reduced 49.39%	204,158 $6.16 Million
Q1 2024 May 13, 2024	BUY	$29.93 - $35.06 $20,262 - $23,735	677 Added 0.17%	403,369 $13.5 Million
Q4 2023 Feb 14, 2024	SELL	$19.2 - $33.78 $1.6 Million - $2.81 Million	-83,299 Reduced 17.14%	402,692 $13 Million
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $2,519 - $3,083	79 Added 0.02%	485,991 $15.9 Million

Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $3.56 Million - $4.37 Million	116,784 Added 31.64%	485,912 $17.1 Million
Q1 2023 May 15, 2023	SELL	$30.8 - $53.92 $211,719 - $370,646	-6,874 Reduced 1.83%	369,128 $12.1 Million
Q4 2022 Feb 14, 2023	SELL	$45.4 - $60.91 $2.15 Million - $2.88 Million	-47,253 Reduced 11.16%	376,002 $20.7 Million
Q3 2022 Nov 14, 2022	SELL	$42.06 - $55.45 $2.94 Million - $3.88 Million	-69,961 Reduced 14.18%	423,255 $18.7 Million
Q2 2022 Aug 15, 2022	BUY	$33.54 - $52.15 $3.09 Million - $4.8 Million	92,130 Added 22.97%	493,216 $24.1 Million
Q1 2022 May 16, 2022	BUY	$33.14 - $51.13 $566,428 - $873,913	17,092 Added 4.45%	401,086 $19.8 Million
Q4 2021 Feb 14, 2022	SELL	$34.09 - $43.91 $2.63 Million - $3.39 Million	-77,272 Reduced 16.75%	383,994 $16.4 Million
Q3 2021 Nov 12, 2021	BUY	$25.68 - $38.61 $3.3 Million - $4.96 Million	128,521 Added 38.62%	461,266 $17.7 Million
Q2 2021 Aug 16, 2021	BUY	$25.96 - $33.44 $7.19 Million - $9.26 Million	276,981 Added 496.7%	332,745 $9.39 Million
Q1 2021 May 17, 2021	BUY	$27.56 - $40.37 $1.26 Million - $1.84 Million	45,607 Added 449.02%	55,764 $1.84 Million
Q4 2020 Feb 16, 2021	BUY	$31.74 - $51.34 $322,383 - $521,460	10,157 New	10,157 $367,000

Others Institutions Holding HRMY

# of Institutions

318

Shares Held

42.8M

Call Options Held

1.05M

Put Options Held

310K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.01B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Harmony Biosciences Holdings, Inc. Transaction History